Taken together these results indicate that effectiveness of combination treatment on melanoma cells is due to an induction of BIM and a simultaneous decrease in expression of anti-apoptotic proteins Bcl-2, Bcl-XL and XIAP. This evidence concerns the gene BCL2 and melanoma.